Rise Therapeutics
Manufacturing · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1405 Research Blvd Ste 220, Rockville, M...Phone Number
(301) 640-5166Website
www.risetherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Rise Therapeutics
Rise Therapeutics is a clinical-stage biotechnology company specializing in precision immunotherapy through innovative oral drug delivery methods. They develop first-in-class Oral Immune BioModulators aimed at treating autoimmune diseases and cancer by modulating immune function with high specificity. The company integrates advanced synthetic biology and clinical GMP manufacturing to ensure the seamless transition from research to patient-ready therapies. Rise Therapeutics seeks partnerships with academic and pharmaceutical leaders to advance their groundbreaking immunotherapy solutions.Explore more
Rise Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rise Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Rise Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Rise Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Rise Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Rise Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Rise Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Rise Therapeutics
Product Launch: Get notified when Rise Therapeutics launches new products
Funding: Get notified immidiatlly once Rise Therapeutics has new funding data
Recommended Actions
Reach out to Masked Content who joined Rise Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Rise Therapeutics
Compare insights from companies similar to Rise Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
$37.5M
2011
Company Profile Activity
Activity Insights
Rise Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rise Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rise Therapeutics.
Rise Therapeutics financials insights
Gather financial insights about Rise Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Other Financing Round
$200K
Rise Therapeutics Tech Stack
A closer look at the technologies used by Rise Therapeutics
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Project
Spending/Investment, Funding
Project
Product Development, Product Management, Medical Research, Clinical Operations
Rise Therapeutics News & Media
Rise Therapeutics Secures New Funding to Advance First-in-Class R-2487 Oral Immune Biomodulator into Sjogren's Disease Clinical Testing
Supported by recent clinical data from the first-ever clinical study of an oral dendritic cell (DC) modulator in rheumatoid arthritis (RA), Rise Therapeutics is expanding into a second autoimmune indication, Sjögren's Disease (SjD) ROCKVILLE, Md., Sept. 23, 2025 /PRNewswire/ -- Rise...Rise Therapeutics Reports Ulcerative Colitis Dose Escalation Clinical Results for R-3750 at the Digestive Disease Week (DDW) Conference in San Diego May 3-6
Results highlight safety and promising clinical responses of R-3750, along with biomarker results demonstrating a differentiated immune mechanism ROCKVILLE, Md., April 7, 2025 /PRNewswire/ -- Rise Therapeutics, a biopharmaceutical company developing precision immunotherapies, today...Rise Therapeutics Receives FDA IND Clearance to Initiate Clinical Testing of R-5780 in Cancer
ROCKVILLE, Md., Jan. 13, 2025 /PRNewswire/ -- Rise Therapeutics, a biotechnology company engaged in developing novel oral Immunotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application to proceed with a...Dose Escalation Completed for Rise Therapeutics' R-3750 and R-2487 Clinical Trials
ROCKVILLE, Md., Jan. 6, 2025 /PRNewswire/ -- Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, today announced that it has completed dose escalation enrollment stages for both its R-2487 and R-3750 clinical trials. Both studies...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rise Therapeutics
Sign Up For FreeTo access detailed company insights
Rise Therapeutics is a clinical-stage biotechnology company specializing in precision immunotherapy through innovative oral drug delivery methods. They develop first-in-class Oral Immune BioModulators aimed at treating autoimmune diseases and cancer by modulating immune function with high specificity. The company integrates advanced synthetic biolo... Read More
